Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 91 (2), 170-180
- https://doi.org/10.1038/labinvest.2010.174
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent modelsJournal of Clinical Investigation, 2009
- MMP9 and SCF Protect from Apoptosis in Acute Kidney InjuryJournal of the American Society of Nephrology, 2009
- MMP-9–Positive Neutrophil Infiltration Is Associated to Blood–Brain Barrier Breakdown and Basal Lamina Type IV Collagen Degradation During Hemorrhagic Transformation After Human Ischemic StrokeStroke, 2008
- Urinary biomarkers in the early diagnosis of acute kidney injuryKidney International, 2008
- Metalloproteinases and their inhibitors: Regulators of wound healingThe International Journal of Biochemistry & Cell Biology, 2007
- Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureBritish Journal of Pharmacology, 2007
- Matrix metalloproteinases as modulators of inflammationSeminars in Cell & Developmental Biology, 2007
- What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?Cardiovascular Research, 2006
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002